Cart
sales@molnova.com
PGP-4008
CAS No. 365565-02-2
PGP-4008( —— )
Catalog No. M34378 CAS No. 365565-02-2
PGP-4008 is a selective and potent P-glycoprotein (Pgp) inhibitor that inhibits tumor growth by co-administration with Doxorubicin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 37 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 105 | In Stock |
|
| 25MG | 199 | In Stock |
|
| 50MG | 308 | In Stock |
|
| 100MG | 461 | In Stock |
|
| 200MG | 624 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePGP-4008
-
NoteResearch use only, not for human use.
-
Brief DescriptionPGP-4008 is a selective and potent P-glycoprotein (Pgp) inhibitor that inhibits tumor growth by co-administration with Doxorubicin.
-
DescriptionPGP-4008 is a specific P-glycoprotein (Pgp) inhibitor. PGP-4008 inhibits tumor growth in a murine syngeneic Pgp-mediated multiple agent resistance (MDR) solid tumor model when given in combination with Doxorubicin.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorP-gp
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number365565-02-2
-
Formula Weight393.48
-
Molecular FormulaC26H23N3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (158.84 mM; Ultrasonic (<60°C)
-
SMILESO=C(Cc1ccccc1)Nc1c2CCN(Cc3ccccc3)c2nc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Brian D Lee, et al. Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein. J Med Chem. 2004 Mar 11;47(6):1413-22.?
molnova catalog
related products
-
GPR120 receptor agon...
A potent and selective GPR120 receptor agonist.
-
SV40 large T antigen...
SV40 large T antigen NLS is from Large T antigen residue 47 to 55, enables protein import into cell nucleus. This peptide is generated from Large T antigen residue 47 to 55.
-
TT01001
TT01001 is a selective agonist of mitoNEET and reduces oxidative stress injury and neuronal apoptosis by improving mitochondrial dysfunction. TT01001 can be used in studies about the treatment of type II diabetes.
